Literature DB >> 16784731

The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats.

Deborah Lonsdale1, Kirk Nylen, W McIntyre Burnham.   

Abstract

Progesterone is a neurosteroid that modulates neuronal excitability. The anticonvulsant effects of progesterone are largely mediated by the actions of its metabolites. The purpose of this study was to measure the anticonvulsant effects of progesterone, 5alpha-dihydroprogesterone, and allopregnanolone against amygdala-kindled seizures in male rats. The amygdala kindling model is a model of human complex partial seizures with secondary generalization. A bipolar electrode was chronically implanted in the right amygdala of male Wistar rats. All subjects were kindled to 30 stage 5 seizures and stability tested. Multiple doses of progesterone, 5alpha-dihydroprogesterone, or allopregnanolone were administered in separate dose-response studies. The antiseizure effects of each compound were determined. A progesterone time-response study was also conducted. At 30 min after injection, progesterone had an ED50 of 65.3 mg/kg against the secondarily generalized seizure and an ED50 of 114 mg/kg against the focal seizure. 5alpha-dihydroprogesterone had a low ED50 of 6.2 mg/kg against both the generalized component of the amygdala-kindled seizure and the focal seizure. Allopregnanolone had an ED50 of 15.2 mg/kg against the secondarily generalized seizure and was not effective against the focal seizure. Progesterone is an effective anticonvulsant against the secondarily generalized component of amygdala-kindled seizures in male rats. Progesterone is only effective against the focal seizure at high ataxic doses. 5alpha-dihydroprogesterone is a potent anticonvulsant against both the kindled amygdala focal discharge and the secondarily generalized seizure. Allopregnanolone is an effective anticonvulsant against the secondarily generalized component of the seizure, but not against the amygdala focal discharge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784731     DOI: 10.1016/j.brainres.2006.05.005

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

2.  Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model.

Authors:  Doodipala S Reddy; Michael A Rogawski
Journal:  Epilepsy Res       Date:  2010-02-20       Impact factor: 3.045

3.  Impact of strain, sex, and estrous cycle on gamma butyrolactone-evoked absence seizures in rats.

Authors:  Victor R Santos; Ihori Kobayashi; Robert Hammack; Gregory Danko; Patrick A Forcelli
Journal:  Epilepsy Res       Date:  2018-09-18       Impact factor: 3.045

4.  Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

Authors:  Doodipala Samba Reddy; Omkaram Gangisetty; Seema Briyal
Journal:  Neuropharmacology       Date:  2010-09-08       Impact factor: 5.250

5.  Hormonal therapies: progesterone.

Authors:  Andrew G Herzog
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

6.  Neuroprotective actions of neurosteroids.

Authors:  Kinga K Borowicz; Barbara Piskorska; Monika Banach; Stanislaw J Czuczwar
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-11       Impact factor: 5.555

7.  Allopregnanolone Decreases Evoked Dopamine Release Differently in Rats by Sex and Estrous Stage.

Authors:  Ana Paula S Dornellas; Giovana C Macedo; Minna H McFarland; Alexander Gómez-A; Todd K O'Buckley; Claudio Da Cunha; A Leslie Morrow; Donita L Robinson
Journal:  Front Pharmacol       Date:  2021-01-14       Impact factor: 5.810

8.  A reliable method for intracranial electrode implantation and chronic electrical stimulation in the mouse brain.

Authors:  Melanie Jeffrey; Min Lang; Jonathan Gane; Chiping Wu; W McIntyre Burnham; Liang Zhang
Journal:  BMC Neurosci       Date:  2013-08-06       Impact factor: 3.288

9.  Neurosteroids and Seizure Activity.

Authors:  Barbara Miziak; Magdalena Chrościńska-Krawczyk; Stanisław J Czuczwar
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.